Christiane Norenberg
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT®.
Journal: Patient preference and adherence
Published: January 17, 2020
Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.
Journal: BMC neurology
Published: March 29, 2018
Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.
Journal: BMC neurology
Published: June 12, 2017
Interferon beta-1b in treatment-naïve paediatric patients with relapsing-remitting multiple sclerosis: Two-year results from the BETAPAEDIC study.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: March 27, 2017
Scheduled versus Pro Re Nata Dosing in the VIEW Trials.
Journal: Ophthalmology
Published: September 30, 2014
Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration.
Journal: Ophthalmology
Published: February 17, 2014
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Journal: Ophthalmology
Published: May 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026